Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
0.7147
-0.0543 (-7.06%)
May 21, 2026, 4:00 PM EDT - Market closed
Skye Bioscience Market Cap
Skye Bioscience has a market cap or net worth of $25.11 million as of May 21, 2026. Its market cap has decreased by -55.49% in one year.
Market Cap
25.11M
Enterprise Value
8.31M
1-Year Change
-55.49%
Ranking
Category
Stock Price
$0.71
Market Cap Chart
Since April 11, 2024, Skye Bioscience's market cap has decreased from $356.10M to $25.11M, a decrease of -92.95%. That is a compound annual growth rate of -71.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 21, 2026 | 25.10M | 4.58% |
| Dec 31, 2025 | 24.00M | -72.06% |
| Dec 31, 2024 | 85.90M | -75.88% |
| Apr 11, 2024 | 356.10M | - |
View and export this data all the way back to 2024. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NeuroSense Therapeutics | 28.63M |
| Outlook Therapeutics | 28.56M |
| Kyntra Bio | 28.13M |
| Barinthus Biotherapeutics | 28.06M |
| IGC Pharma | 27.76M |
| ABVC BioPharma | 27.18M |
| Palatin Technologies | 27.01M |
| Tempest Therapeutics | 26.68M |